Enanta Pharmaceuticals Inc.

(ENTA) Trade

By |

Profile

Enanta Pharmaceuticals Inc is an American biotechnology company focused on research and development of molecule drugs to cure viral infections and liver diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of the company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

Contact Information

Website: www.enanta.com
Email: cmiceli@enanta.com
Main Phone: +1 617 607-0800
Address: 500 Arsenal Street
State: MA
City / Town: Watertown
Country: USA
Postal Code: 02472

Issuer Information

Exchange: NGS
CEO: Jay R. Luly
Employees: 113
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 75.00 $ 0. (0.00%)
Last Price 75.00 Change $ 0. Change % 0.00 Tick N/A
Bid 74.00 Bid Size 100.00 Ask 95.00 Ask Size 200.00
Open N/A High N/A Low N/A Prev Close 75.00
Last Trade Volume 0 52 Wk Hi 127.77 52 Wk Low 47.49
Market Cap 1.5 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 19,423,949.00 EPS (TTM) 3.48 PE Ratio 21.00 Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 18 37
Number of Buys 2 15
Number of Sells 16 22
Net Activity -51470 -1807
Last 10 Buys Shares
Nathaniel S. Gardiner 1,000
Terry Vance 1,000
Stephen Buckley 1,000
Stephen Buckley 1,000
Nathaniel S. Gardiner 1,000
Nathaniel S. Gardiner 1,000
Nathaniel S. Gardiner 1,000
Stephen Buckley 1,000
Gregory L. Verdine 1,000
Terry Vance 1,000
Last 10 Sell Shares
Paul J. Mellett 1,000
Paul J. Mellett 1,000
Paul J. Mellett 1,000
Paul J. Mellett 1,000
Paul J. Mellett 1,000
Jay R. Luly 1,000
Nathalie Adda 1,000
Nathalie Adda 1,000
Nathalie Adda 1,000
Jay R. Luly 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 135 135 105 135
Low Target Price Estimate 82 82 58 82
Mean Target Price Estimate 111 105.5 81.67 111
Standard Deviation 22.68 22.01 23.5 22.68
Date of Most Recent Estimate 06/06/18 05/24/18 05/09/18 06/06/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 1 1 1
Moderate Buy 0 0 0 0
Hold 3 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2 2.5 2.5 2.5